ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1512

Bone Structural Deficits in Rheumatoid Arthritis: Impact of Muscle Mass and Density

Joshua Baker1, Jin Long2, Babette S. Zemel3, Janet E. Dinnella4, Prerna Sharma5, Said Ibrahim6 and Mary B. Leonard7, 1Medicine/Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Stanford University, Palo Alto, CA, 3Pediatrics, The Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 4Arthritis/Immun Center, U Penn & VA Med Ctr, Philadelphia, PA, 5University of Pennsylvania, Philadelphia, PA, 6Medicine, University of Pennsylvania, Philadelphia, PA, 7Pediatrics, Division of Nephrology, Stanford School of Medicine, Stanford University, Palo Alto, CA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: adipose tissue, Bone, muscle strength and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is associated with muscle loss, obesity, and osteoporotic fractures. Body composition and muscle quality are important regulators of bone strength among healthy adults. This study determined if patients with RA have deficits in cortical bone thickness (CBT; a structural measure highly correlated with fracture load) and trabecular bone density (TBD; a measure of volumetric bone mineral density) relative to their body mass. The study also assessed the degree to which these deficits are related to deficits in skeletal muscle.

Methods: Participants with RA, ages 18-75 years, were recruited from academic practices (2012-2016) and compared to a reference sample of healthy controls (ages 21 to 80). Participants underwent peripheral quantitative CT (pQCT) of the tibia to measure CBT and TBD as well as muscle cross-sectional area and density and fat area. Whole-body DXA measured appendicular lean mass index (ALMI), and fat mass index (FMI). BMI and body composition measures were converted to age-, sex, and race-specific Z-Scores.  Multivariable linear regression models evaluated independent associations between body composition exposures and bone outcomes in RA and controls with assessment for altered associations in RA.

Results: The study consisted of 102 RA patients (50 men) and 416 controls (192 men). Patients with RA had greater BMI (p=0.004), greater total fat mass (p=0.02) and lower adiposity-adjusted ALMI Z-Scores (p=0.004), and low muscle density Z-Scores (p<0.0001). TBD and CBT Z-Scores were similar in RA and controls. However, RA patients had lower Z-Scores for bone outcomes compared to controls with similar BMI Z-Score (Figure). Sequential adjustment for ALMI, FMI, and muscle density Z-Scores in linear regression models attenuated these associations. Results were similar in analyses incorporating pQCT muscle and fat cross-sectional area Z-Scores. Relationships between body composition and bone outcomes were similar in RA and controls (no interaction) (Table). Men with RA had lower TBD Z-Scores than women with RA (p=0.005). Disease duration >10 years was associated with lower TBD (p=0.07) and CBT (p=0.04) independent of sex, ALMI, and FMI.

Conclusion: Patients with RA have bone structure and density that is maladapted to their weight. Muscle deficits in RA likely contribute to bone deficits through a loss of mechanical loading. Deficits in muscle mass and quality are, therefore, under-recognized risk factors for maladapted bone structure in RA; potentially impacting the long-term risk of fracture.

Table: Beta-coefficients representing associations between body composition and bone structure outcomes in patients with RA and controls. RA has similar relationships (no significant disease interaction) between body composition, muscle quality and bone outcomes.

Rheumatoid Arthritis (N=102)

Controls (N=416)

 TRABECULAR DENSITY Z-SCORE

β (95%CI) p-value β (95%CI) p-value
ALMI Z-Score 0.33 (0.053, 0.61) 0.02 0.34 (0.21, 0.47) 0.001
FMI Z-Score 0.12 (-0.12, 0.36) 0.33 0.0062 (-0.088, 0.15) 0.90
Muscle Density Z-Score 0.099 (-0.099, 0.30) 0.33 0.10 (0.011, 0.20) 0.03

CORTICAL THICKNESS Z-SCORE

β (95%CI) p-value β (95%CI) p-value
ALMI Z-Score 0.35 (0.11, 0.59) 0.004 0.45 (0.33, 0.58) <0.001
FMI Z-Score -0.04 (-0.23, 0.17) 0.77 -0.027 (-0.15, 0.092) 0.66
Muscle Density Z-Score 0.12 (-0.039, 0.29) 0.14 0.089 (-0.0023, 0.18) 0.06

Disclosure: J. Baker, None; J. Long, None; B. S. Zemel, None; J. E. Dinnella, None; P. Sharma, None; S. Ibrahim, None; M. B. Leonard, None.

To cite this abstract in AMA style:

Baker J, Long J, Zemel BS, Dinnella JE, Sharma P, Ibrahim S, Leonard MB. Bone Structural Deficits in Rheumatoid Arthritis: Impact of Muscle Mass and Density [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/bone-structural-deficits-in-rheumatoid-arthritis-impact-of-muscle-mass-and-density/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bone-structural-deficits-in-rheumatoid-arthritis-impact-of-muscle-mass-and-density/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology